𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alpha-synuclein promoter haplotypes and dementia in Parkinson's Disease

✍ Scribed by E.V. De Marco; P. Tarantino; F.E. Rocca; G. Provenzano; D. Civitelli; V. De Luca; F. Annesi; S. Carrideo; I.C. Cirò Candiano; N. Romeo; G. Nicoletti; R. Marconi; F. Novellino; M. Morelli; A. Quattrone; G. Annesi


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
71 KB
Volume
147B
Category
Article
ISSN
1552-4841

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Dementia is a common complication of Parkinson's disease (PD). It correlates significantly with the presence of cortical, limbic or nigral Lewy bodies, mainly constituted of alpha‐synuclein. Mutations of the alpha‐synuclein gene (SNCA) have been linked to rare familial forms of PD, while association studies on the promoter polymorphisms have given conflicting results in sporadic patients. We have performed a case control study to investigate whether genetic variability in the promoter of the alpha‐synuclein gene could predispose to dementia in PD. A total of 114 demented patients and 114 non‐demented patients with sporadic PD were included in the study. Six polymorphic loci (including the Rep1 microsatellite) in the promoter of the SNCA gene were examined. Each marker, taken individually, did not show association to dementia and no significant differences were observed in the inferred haplotype frequencies of demented and non‐demented patients. Our data suggest the lack of involvement of the SNCA promoter in the pathogenesis of dementia in PD. Further studies in other populations are needed to confirm these results. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES